Neervannan Seshadri

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 69% 68% 82%
Transactions
13 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Neervannan Seshadri's trades of Tarsus Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
313.70
Quantity 98,356
Value US$4,536,491
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-09 2026-09-04
PlS Planned sale
3,211 -24.5%
248.55
US$2,752,665 		3,211 -24.5% 248.55 US$2,752,665
2026-09-04 2026-09-04
PrS Proposed sale
98,356
313.70
US$4,536,491 		98,356 313.70 US$4,536,491
2026-03-24 2026-03-20
PlS Planned sale
42,697 +9.1%
305.20
US$4,905,022 		42,697 +9.1% 305.20 US$4,905,022
2026-03-20 2026-03-20
PrS Proposed sale
2,989
66.75
US$199,516 		2,989 66.75 US$199,516
2026-03-19 2026-03-19
S Sale
4,589 -5.1%
67.00
US$307,463 		4,589 -5.1% 67.00 US$307,463
2026-03-19 2026-03-19
PrS Proposed sale
4,589
67.00
US$307,457 		4,589 67.00 US$307,457
2026-03-19 2026-03-18
S Sale
3,610 -3.8%
68.71
US$248,043 		3,610 -3.8% 68.71 US$248,043
2026-03-18 2026-03-18
PrS Proposed sale
3,610
68.71
US$248,042 		3,610 68.71 US$248,042
2026-03-19 2026-03-17
S Sale
3,125 -3.2%
69.42
US$216,938 		3,125 -3.2% 69.42 US$216,938
2026-03-17 2026-03-17
PrS Proposed sale
3,125
69.41
US$216,921 		3,125 69.41 US$216,921
2026-03-05 2026-03-04
PlS Planned sale
8,366 -10.6%
76.67
US$641,421 		8,366 -10.6% 76.67 US$641,421
2026-03-04 2026-03-04
PrS Proposed sale
8,366
76.67
US$641,421 		8,366 76.67 US$641,421
2025-03-20 2025-03-20
PrS Proposed sale
2,435
50.11
US$122,026 		2,435 50.11 US$122,026
2025-03-20 2025-03-20
S Sale
2,435 -3.0%
50.11
US$122,018 		2,435 -3.0% 50.11 US$122,018
2025-03-20 2025-03-19
S Sale
2,543 -3.0%
47.40
US$120,538 		2,543 -3.0% 47.40 US$120,538
2025-03-19 2025-03-19
PrS Proposed sale
2,543
47.40
US$120,536 		2,543 47.40 US$120,536
2025-03-20 2025-03-18
S Sale
2,605 -3.0%
46.29
US$120,585 		2,605 -3.0% 46.29 US$120,585
2025-03-18 2025-03-18
PrS Proposed sale
2,605
46.28
US$120,571 		2,605 46.28 US$120,571
2024-03-19 2024-03-18
S Sale
4,879 -7.0%
30.60
US$149,297 		4,879 -7.0% 30.60 US$149,297
2024-03-18 2024-03-18
PrS Proposed sale
4,879
30.60
US$149,285 		4,879 30.60 US$149,285
2023-03-23 2023-03-23
S Sale
390 -0.7%
12.15
US$4,738 		390 -0.7% 12.15 US$4,738
2023-03-23 2023-03-22
S Sale
379 -0.7%
12.64
US$4,791 		379 -0.7% 12.64 US$4,791
2023-03-23 2023-03-21
S Sale
372 -0.7%
12.89
US$4,795 		372 -0.7% 12.89 US$4,795
2023-03-21 2023-03-20
S Sale
380 -0.7%
12.61
US$4,792 		380 -0.7% 12.61 US$4,792
2023-03-21 2023-03-17
S Sale
360 -0.6%
13.28
US$4,781 		360 -0.6% 13.28 US$4,781
2023-03-17 2023-03-16
S Sale
357 -0.6%
13.43
US$4,795 		357 -0.6% 13.43 US$4,795
2023-03-16 2023-03-16
PrS Proposed sale
2,300
13.66
US$31,418 		2,300 13.66 US$31,418